Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 5423043, 5 pages
http://dx.doi.org/10.1155/2016/5423043
Research Article

The Role of Fecal Calprotectin in Evaluating Intestinal Involvement of Behçet’s Disease

1Division of Gastroenterology, Department of Internal Medicine, School of Medicine, Muğla Sıtkı Koçman University, 48000 Muğla, Turkey
2Department of Internal Medicine, School of Medicine, Muğla Sıtkı Koçman University, 48000 Muğla, Turkey
3Department of Pathology, Education and Research Hospital, Muğla Sıtkı Koçman University, 48000 Muğla, Turkey
4Gastroenterology Unit, Batman State Hospital, 72070 Batman, Turkey
5Department of Internal Medicine, Division of Gastroenterology, School of Medicine, Hacettepe University, 06230 Ankara, Turkey

Received 28 January 2016; Revised 31 May 2016; Accepted 2 June 2016

Academic Editor: Paul Ashwood

Copyright © 2016 Burak Özşeker et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Sakane, M. Takeno, N. Suzuki, and G. Inaba, “Behcet's disease,” The New England Journal of Medicine, vol. 341, no. 17, pp. 1284–1291, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. International Study Group for Behçet's Disease, “Criteria for diagnosis of Behcet's disease,” The Lancet, vol. 335, no. 8697, pp. 1078–1080, 1990. View at Publisher · View at Google Scholar · View at Scopus
  3. S. W. Yi, J. H. Cheon, J. H. Kim et al., “The prevalence and clinical characteristics of esophageal involvement in patients with Behçet's disease: a single center experience in Korea,” Journal of Korean Medical Science, vol. 24, no. 1, pp. 52–56, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. I. J. Choi, J. S. Kim, S. D. Cha et al., “Long-term clinical course and prognostic factors in intestinal Behçet's disease,” Diseases of the Colon and Rectum, vol. 43, no. 5, pp. 692–700, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Iida, H. Kobayashi, T. Matsumoto et al., “Intestinal Behçet disease: serial changes at radiography,” Radiology, vol. 188, no. 1, pp. 65–69, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Oktayoglu, N. Mete, M. Caglayan et al., “Elevated serum levels of calprotectin (MRP8/MRP14) in patients with Behçet's disease and its association with disease activity and quality of life,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 75, no. 2, pp. 106–112, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. Q.-J. Wu, F.-C. Zhang, and X. Zhang, “Adamantiades-Behcet's disease-complicated gastroenteropathy,” World Journal of Gastroenterology, vol. 18, no. 7, pp. 609–615, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. U. Tursen, A. Gurler, and A. Boyvat, “Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease,” International Journal of Dermatology, vol. 42, no. 5, pp. 346–351, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Kobayashi, F. Ueno, S. Bito et al., “Development of consensus statements for the diagnosis and management of intestinal Behçet's disease using a modified Delphi approach,” Journal of Gastroenterology, vol. 42, no. 9, pp. 737–745, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Köklü, O. Yüksel, L. Onur et al., “Ileocolonic involvement in Behçet's disease: endoscopic and histological evaluation,” Digestion, vol. 81, no. 4, pp. 214–217, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Gubler and P. Bauerfeind, “Intestinal Behçet's disease diagnosed by capsule endoscopy,” Endoscopy, vol. 37, no. 7, p. 689, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. S. Hamdulay, K. Cheent, C. Ghosh, J. Stocks, S. Ghosh, and D. O. Haskard, “Wireless capsule endoscopy in the investigation of intestinal Behçet's syndrome,” Rheumatology, vol. 47, no. 8, pp. 1231–1234, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. P. F. van Rheenen, E. van de Vijver, and V. Fidler, “Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis,” British Medical Journal, vol. 341, no. 7765, Article ID c3369, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. E. K. Wright, “Calprotectin or lactoferrin: do they help,” Digestive Diseases, vol. 34, no. 1-2, pp. 98–104, 2016. View at Publisher · View at Google Scholar
  15. K. Theede, S. Holck, P. Ibsen, T. Kallemose, I. Nordgaard-Lassen, and A. M. Nielsen, “Fecal calprotectin predicts relapse and histological mucosal healing in ulcerative colitis,” Inflammatory Bowel Diseases, vol. 22, no. 5, pp. 1042–1048, 2016. View at Publisher · View at Google Scholar
  16. N. E. Walsham and R. A. Sherwood, “Fecal calprotectin in inflammatory bowel disease,” Clinical and Experimental Gastroenterology, vol. 9, pp. 21–29, 2016. View at Publisher · View at Google Scholar
  17. A. Duran, S. Kobak, N. Sen, S. Aktakka, T. Atabay, and M. Orman, “Fecal calprotectin is associated with disease activity in patients with ankylosing spondylitis,” Bosnian Journal of Basic Medical Sciences, vol. 16, no. 1, pp. 71–74, 2016. View at Publisher · View at Google Scholar